Trials / Active Not Recruiting
Active Not RecruitingNCT00568139
Evaluation of Side Effects of Mitotane
Evaluierung Von Nebenwirkungen Einer Therapie Mit Mitotane Beim Nebennierenkarzinom- Evaluation of Side Effects of Mitotane in Adrenocortical Carcinoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University of Wuerzburg · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Mitotane is standard therapy in the treatment of adrenocortical carcinoma. However, many adverse effects are not well documented. Therefore, we are aiming at collecting data about adverse effects in patients treated with mitotane
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2025-12-01
- Completion
- 2027-12-01
- First posted
- 2007-12-05
- Last updated
- 2025-08-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00568139. Inclusion in this directory is not an endorsement.